A coronavirus (SARS-CoV-2) has caused a global pandemic and associated morbidity and mortality resultant from COVID-19. As a result of efforts to control direct (person to person) and indirect (contaminated objects, surfaces, indoor air) transmission of the virus, various interventions have been evaluated. Studies were conducted to evaluate the efficacy of commercially available chlorine dioxide (CD) products to reduce viral loads on PPE (face masks) and surfaces using a novel dry gas release intervention. The efficacy of CD slow release 30-day sachets was tested on N95 face masks inoculated with human coronavirus OC43 in suspension. One sachet was placed with an inoculated mask in plastic resealable bags. Three trials were completed using the original sachet where a mask and sachet were placed into a plastic bag for 13 hours per sachet age of 1 day, 14 days, and 30 days. The amount of CD generated during a 13-hour treatment period was 0.30 mg. The nominal concentration of CD was estimated to be 317 mg/m 3. All three tests demonstrated at least a 99.91% reduction of viral loading in the mask versus a non-treated control. Efficacy of CD dry gas fast releasing pods (Ultrashok) for fumigation was also tested in a 1344 ft 3 closed room. Two pods were placed in the space and CD surface virucidal efficacy was tested in three locations of the room after 1 hour and 2 hours of dwell time. The estimated nominal peak concentration was 15 ppmv in the room. The one-hour exposure saw a >99.91% OC43 reduction on surfaces and the two-hour exposure resulted in a >99.997% OC43 reduction on surfaces versus a non-treated control. These results indicate dry CD is highly effective against human coronavirus. CD was 99.91% effective for eliminating human coronavirus OC43 in both sachet and capsule fumigant form using both fast and slow release mechanisms. Rapid fumigant application is suitable for contaminated rooms, ambulances, emergency vehicles, and many types of PPE, most particularly porous PPE materials. The gaseous state of CD allows for rapid diffusion and transfer of the virucidal stable free radical to all surfaces of PPE and indoor areas that would favor virus survival. Additionally, this work suggests CD can be effective at levels with significant margins of safety (little to no exposure and rapid degradation of residuals) providing minimal public health risks associated with the use of CD.
Chlorine dioxide is currently approved by the United States Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) for many antimicrobial uses, including water purification and food decontamination, thus increasing the shelf life of fruit, vegetables, and meat [
December of 2019 saw the rise of a novel coronavirus (COVID-19) and has since grown into a global pandemic. As a result, the United States has seen shortages of personal protective equipment (PPE), leading to unnecessarily increased risk for people caring for COVID-19 positive patients like hospital workers and emergency medical technicians. CD’s virucidal properties, lack of residue, and safety make it ideal for reusing various PPE such as N95 masks. This would also be applicable on a bigger scale when applied to surfaces in rooms that have been contaminated with the virus. Relatively short fumigation of enclosed spaces would allow for fast sterilization with less manual labor required of the cleaning staff.
Currently, liquid antimicrobial solutions like hydrogen peroxide and phenols are used to manually disinfect various spaces such as operating rooms and ambulances. CD’s gaseous state allows it to reach and disinfect even the smallest crevices that may otherwise be ignored. CD is commercially sold across the country. One such company called ICA Tri-Nova, LLC produces delayed-release CD products that range from 1 hour to 30 days, to be used for water purification, odor reduction, and more. One of its products is the StayFresh UltraShok, which is a small pod that quickly releases CD gas for up to 1 hour. The purpose of this study was to evaluate the virucidal efficacy of this product for reducing coronavirus contaminated facemasks and surfaces.
The test material was contained in a sachet shown in
Surface virucidal efficacy was tested using plastic capsules shown in
room. The size of the room was 1344 ft3 (approximately 7' × 24' × 8'). The study was conducted as per laboratory protocol adaptation from ASTM E1053 [
Three carriers were placed at locations open to room air. Two of the capsules were placed on the floor in the room and spaced at equal length intervals. The temperature of the room was maintained at 19 - 21 degrees C. This resulted in low relative humidity (RH). An ultrasonic humidifier was placed into the room to maintain humidity at 75% - 85% RH. Additionally, a small 510 CFM fan was also placed in the room to allow air circulation and homogeneity of conditions in the room. The capsules were activated and immediately the room was vacated and sealed. The room was allowed a dwell time of 1 and 2 hours.
The room was opened, a mild chlorine-based odor was noted but it was not overwhelming or irritating. Each of the carriers was removed, immediately added to sterile containers with 10 mL of D/E Neutralizing Broth, and homogenized. The samples were analyzed for viable infectious coronavirus OC43 on the day of the study at undiluted and at ten-fold dilutions in replicates of five. Additionally, two control glass carriers were inoculated as above but maintained in a separate area not exposed to the gas. They were processed similarly following recovery of treatment carriers. These served as recovery controls. The number of microorganisms recovered from the controls was used to calculate the starting concentration. Positive, negative and neutralization controls were included with test materials to provide quality control and reference data as per laboratory standard accredited ISO17025:2017 methodology [
Viable virus was analyzed using HRT-18G cell infectivity assay. Cell monolayers were monitored for cytopathic effect development over a 14-day period. Viruses were enumerated as Infectious Units (I.U.) using the Most Probably Number (MPN) analysis of the cell culture results. Analysis was conducted as per method EPA/600/R-95/178 [
Gas releasing sachets effectively decontaminated N95 facemasks. Facemasks contaminated with human coronavirus OC43 and exposed to chlorine dioxide gas for 13 hours were decontaminated with a 99.9% reduction of the virus in the facemasks, shown in
Gas releasing plastic capsules effectively eliminated virus contaminated surfaces. Surfaces contaminated with virus were placed at various locations in an enclosed room and subsequently exposed to chlorine dioxide gas. Chlorine dioxide gas exposure eliminated 99.99% of the surface virus. Infectious virus was not detected on contaminated surfaces at 1 and 2 hours following chlorine dioxide fumigation in
Chlorine dioxide was greater than 99.9% effective at eliminating human coronavirus OC43 contamination in facemasks and on room surfaces.
Chlorine dioxide gas was reported as effective at preventing aerosol-induced influenza virus infection [
Funding for laboratory testing at BCS Laboratories was provided by ICA Tri-Nova, LLC.
The authors declare no conflicts of interest regarding the publication of this paper.
Driver, J., Lukasik, G., Bourgeois, M., Tam, P. and Harbison, R. (2021) Virucidal Activity of Chlorine Dioxide Gas for Reduction of Coronavirus on Surfaces and PPE. Occupational Diseases and Environmental Medicine, 9, 13-19. https://doi.org/10.4236/odem.2021.91002